Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

DOI record: { "DOI": "10.1016/s0140-6736(20)32013-4", "ISSN": [ "0140-6736" ], "URL": "http://dx.doi.org/10.1016/S0140-6736(20)32013-4", "alternative-id": [ "S0140673620320134" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial" }, { "label": "Journal Title", "name": "journaltitle", "value": "The Lancet" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/S0140-6736(20)32013-4" }, { "label": "CrossRef DOI link to the associated document", "name": "associatedlink", "value": "https://doi.org/10.1016/S0140-6736(20)32078-X" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2020 The Author(s). Published by Elsevier Ltd." } ], "author": [ { "affiliation": [], "family": "Horby", "given": "Peter W", "sequence": "first" }, { "affiliation": [], "family": "Mafham", "given": "Marion", "sequence": "additional" }, { "affiliation": [], "family": "Bell", "given": "Jennifer L", "sequence": "additional" }, { "affiliation": [], "family": "Linsell", "given": "Louise", "sequence": "additional" }, { "affiliation": [], "family": "Staplin", "given": "Natalie", "sequence": "additional" }, { "affiliation": [], "family": "Emberson", "given": "Jonathan", "sequence": "additional" }, { "affiliation": [], "family": "Palfreeman", "given": "Adrian", "sequence": "additional" }, { "affiliation": [], "family": "Raw", "given": "Jason", "sequence": "additional" }, { "affiliation": [], "family": "Elmahi", "given": "Einas", "sequence": "additional" }, { "affiliation": [], "family": "Prudon", "given": "Benjamin", "sequence": "additional" }, { "affiliation": [], "family": "Green", "given": "Christopher", "sequence": "additional" }, { "affiliation": [], "family": "Carley", "given": "Simon", "sequence": "additional" }, { "affiliation": [], "family": "Chadwick", "given": "David", "sequence": "additional" }, { "affiliation": [], "family": "Davies", "given": "Matthew", "sequence": "additional" }, { "affiliation": [], "family": "Wise", "given": "Matthew P", "sequence": "additional" }, { "affiliation": [], "family": "Baillie", "given": "J Kenneth", "sequence": "additional" }, { "affiliation": [], "family": "Chappell", "given": "Lucy C", "sequence": "additional" }, { "affiliation": [], "family": "Faust", "given": "Saul N", "sequence": "additional" }, { "affiliation": [], "family": "Jaki", "given": "Thomas", "sequence": "additional" }, { "affiliation": [], "family": "Jefferey", "given": "Katie", "sequence": "additional" }, { "affiliation": [], "family": "Lim", "given": "Wei Shen", "sequence": "additional" }, { "affiliation": [], "family": "Montgomery", "given": "Alan", "sequence": "additional" }, { "affiliation": [], "family": "Rowan", "given": "Kathryn", "sequence": "additional" }, { "affiliation": [], "family": "Juszczak", "given": "Edmund", "sequence": "additional" }, { "affiliation": [], "family": "Haynes", "given": "Richard", "sequence": "additional" }, { "affiliation": [], "family": "Landray", "given": "Martin J", "sequence": "additional" } ], "container-title": "The Lancet", "container-title-short": "The Lancet", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "thelancet.com", "em-consulte.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2020, 10, 5 ] ], "date-time": "2020-10-05T22:31:41Z", "timestamp": 1601937101000 }, "deposited": { "date-parts": [ [ 2020, 10, 23 ] ], "date-time": "2020-10-23T10:43:18Z", "timestamp": 1603449798000 }, "indexed": { "date-parts": [ [ 2024, 9, 14 ] ], "date-time": "2024-09-14T00:35:43Z", "timestamp": 1726274143535 }, "is-referenced-by-count": 507, "issue": "10259", "issued": { "date-parts": [ [ 2020, 10 ] ] }, "journal-issue": { "issue": "10259", "published-print": { "date-parts": [ [ 2020, 10 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 10, 1 ] ], "date-time": "2020-10-01T00:00:00Z", "timestamp": 1601510400000 } }, { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 9, 29 ] ], "date-time": "2020-09-29T00:00:00Z", "timestamp": 1601337600000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0140673620320134?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0140673620320134?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "1345-1352", "prefix": "10.1016", "published": { "date-parts": [ [ 2020, 10 ] ] }, "published-print": { "date-parts": [ [ 2020, 10 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1016/S1473-3099(20)30243-7", "article-title": "Estimates of the severity of coronavirus disease 2019: a model-based analysis", "author": "Verity", "doi-asserted-by": "crossref", "first-page": "669", "journal-title": "Lancet Infect Dis", "key": "10.1016/S0140-6736(20)32013-4_bib1", "volume": "20", "year": "2020" }, { "article-title": "Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study", "author": "Docherty", "journal-title": "BMJ", "key": "10.1016/S0140-6736(20)32013-4_bib2", "volume": "369", "year": "2020" }, { "article-title": "Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review", "author": "Dagens", "journal-title": "BMJ", "key": "10.1016/S0140-6736(20)32013-4_bib3", "volume": "369", "year": "2020" }, { "DOI": "10.1016/j.jtbi.2008.07.030", "article-title": "Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors", "author": "Nukoolkarn", "doi-asserted-by": "crossref", "first-page": "861", "journal-title": "J Theor Biol", "key": "10.1016/S0140-6736(20)32013-4_bib4", "volume": "254", "year": "2008" }, { "DOI": "10.1016/j.jgg.2020.02.001", "article-title": "Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines", "author": "Liu", "doi-asserted-by": "crossref", "first-page": "119", "journal-title": "J Genet Genomics", "key": "10.1016/S0140-6736(20)32013-4_bib5", "volume": "47", "year": "2020" }, { "DOI": "10.1016/j.jcv.2004.03.003", "article-title": "In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds", "author": "Chen", "doi-asserted-by": "crossref", "first-page": "69", "journal-title": "J Clin Virol", "key": "10.1016/S0140-6736(20)32013-4_bib6", "volume": "31", "year": "2004" }, { "DOI": "10.1128/AAC.03011-14", "article-title": "Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture", "author": "de Wilde", "doi-asserted-by": "crossref", "first-page": "4875", "journal-title": "Antimicrob Agents Chemother", "key": "10.1016/S0140-6736(20)32013-4_bib7", "volume": "58", "year": "2014" }, { "DOI": "10.1038/s41467-019-13940-6", "article-title": "Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV", "author": "Sheahan", "doi-asserted-by": "crossref", "first-page": "222", "journal-title": "Nat Commun", "key": "10.1016/S0140-6736(20)32013-4_bib8", "volume": "11", "year": "2020" }, { "DOI": "10.1016/j.antiviral.2020.104786", "article-title": "Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro", "author": "Choy", "doi-asserted-by": "crossref", "journal-title": "Antiviral Res", "key": "10.1016/S0140-6736(20)32013-4_bib9", "volume": "178", "year": "2020" }, { "DOI": "10.1093/infdis/jiv392", "article-title": "Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset", "author": "Chan", "doi-asserted-by": "crossref", "first-page": "1904", "journal-title": "J Infect Dis", "key": "10.1016/S0140-6736(20)32013-4_bib10", "volume": "212", "year": "2015" }, { "DOI": "10.1128/mBio.01114-20", "article-title": "Antiviral efficacies of FDA-approved drugs against SARS-CoV-2 infection in ferrets", "author": "Park", "doi-asserted-by": "crossref", "first-page": "e01114", "journal-title": "MBio", "key": "10.1016/S0140-6736(20)32013-4_bib11", "volume": "11", "year": "2020" }, { "DOI": "10.1136/thorax.2003.012658", "article-title": "Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings", "author": "Chu", "doi-asserted-by": "crossref", "first-page": "252", "journal-title": "Thorax", "key": "10.1016/S0140-6736(20)32013-4_bib12", "volume": "59", "year": "2004" }, { "DOI": "10.1183/13993003.00799-2020", "article-title": "Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection", "author": "Yan", "doi-asserted-by": "crossref", "journal-title": "Eur Respir J", "key": "10.1016/S0140-6736(20)32013-4_bib13", "volume": "56", "year": "2020" }, { "article-title": "Clinical efficacy of lopinavir/ritonavir in the treatment of coronavirus disease 2019", "author": "Ye", "first-page": "3390", "journal-title": "Eur Rev Med Pharmacol Sci", "key": "10.1016/S0140-6736(20)32013-4_bib14", "volume": "24", "year": "2020" }, { "DOI": "10.1186/s13054-020-03117-9", "article-title": "Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis", "author": "Lecronier", "doi-asserted-by": "crossref", "first-page": "418", "journal-title": "Crit Care", "key": "10.1016/S0140-6736(20)32013-4_bib15", "volume": "24", "year": "2020" }, { "DOI": "10.1007/s40264-020-00966-9", "article-title": "Lopinavir–ritonavir in the treatment of COVID-19: a dynamic systematic benefit–risk assessment", "author": "Osborne", "doi-asserted-by": "crossref", "first-page": "809", "journal-title": "Drug Saf", "key": "10.1016/S0140-6736(20)32013-4_bib16", "volume": "43", "year": "2020" }, { "DOI": "10.1056/NEJMoa2001282", "article-title": "A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19", "author": "Cao", "doi-asserted-by": "crossref", "first-page": "1787", "journal-title": "N Engl J Med", "key": "10.1016/S0140-6736(20)32013-4_bib17", "volume": "382", "year": "2020" }, { "DOI": "10.1056/NEJMc2008043", "article-title": "A trial of lopinavir–ritonavir in Covid-19", "author": "Havlichek", "doi-asserted-by": "crossref", "first-page": "e68", "journal-title": "N Engl J Med", "key": "10.1016/S0140-6736(20)32013-4_bib18", "volume": "382", "year": "2020" }, { "article-title": "Dexamethasone in hospitalized patients with Covid-19—preliminary report", "author": "Horby", "journal-title": "N Engl J Med", "key": "10.1016/S0140-6736(20)32013-4_bib19", "year": "2020" }, { "article-title": "Effect of hydroxychloroquine in hospitalized patients with COVID-19: preliminary results from a multi-centre, randomized, controlled trial", "author": "Horby", "journal-title": "medRxiv", "key": "10.1016/S0140-6736(20)32013-4_bib20", "year": "2020" }, { "DOI": "10.1016/j.phrs.2020.104898", "article-title": "Does lopinavir really inhibit SARS-CoV-2?", "author": "Cattaneo", "doi-asserted-by": "crossref", "journal-title": "Pharmacol Res", "key": "10.1016/S0140-6736(20)32013-4_bib22", "volume": "158", "year": "2020" }, { "DOI": "10.1002/cpt.1909", "article-title": "Prioritization of anti-SARS-Cov-2 drug repurposing opportunities based on plasma and target site concentrations derived from their established human pharmacokinetics", "author": "Arshad", "doi-asserted-by": "crossref", "journal-title": "Clin Pharmacol Ther", "key": "10.1016/S0140-6736(20)32013-4_bib23", "year": "2020" }, { "DOI": "10.7326/M20-1550", "article-title": "Pharmacokinetics of lopinavir and ritonavir in patients hospitalized with coronavirus disease 2019 (COVID-19)", "author": "Schoergenhofer", "doi-asserted-by": "crossref", "journal-title": "Ann Intern Med", "key": "10.1016/S0140-6736(20)32013-4_bib24", "year": "2020" }, { "DOI": "10.1093/jac/dkaa195", "article-title": "Lopinavir pharmacokinetics in COVID-19 patients", "author": "Gregoire", "doi-asserted-by": "crossref", "first-page": "2702", "journal-title": "J Antimicrob Chemother", "key": "10.1016/S0140-6736(20)32013-4_bib25", "volume": "75", "year": "2020" }, { "DOI": "10.1093/jac/dkaa190", "article-title": "Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose?", "author": "Baldelli", "doi-asserted-by": "crossref", "first-page": "2704", "journal-title": "J Antimicrob Chemother", "key": "10.1016/S0140-6736(20)32013-4_bib26", "volume": "75", "year": "2020" }, { "DOI": "10.1128/AAC.01177-20", "article-title": "Effect of systemic inflammatory response to SARS-CoV-2 on lopinavir and hydroxychloroquine plasma concentrations", "author": "Marzolini", "doi-asserted-by": "crossref", "first-page": "e01177", "journal-title": "Antimicrob Agents Chemother", "key": "10.1016/S0140-6736(20)32013-4_bib27", "volume": "64", "year": "2020" }, { "DOI": "10.1097/QAI.0b013e318232b057", "article-title": "Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children", "author": "Best", "doi-asserted-by": "crossref", "first-page": "385", "journal-title": "J Acquir Immune Defic Syndr", "key": "10.1016/S0140-6736(20)32013-4_bib28", "volume": "58", "year": "2011" }, { "DOI": "10.1093/jac/dkaa261", "article-title": "Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients", "author": "Lê", "doi-asserted-by": "crossref", "first-page": "2657", "journal-title": "J Antimicrob Chemother", "key": "10.1016/S0140-6736(20)32013-4_bib29", "volume": "75", "year": "2020" } ], "reference-count": 28, "references-count": 28, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0140673620320134" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "396" }